Literature DB >> 9431969

Comparison of six sets of PCR primers from two different genomic regions for amplification of GB virus C/hepatitis G virus RNA.

A Andonov1, C Sauder, H Jacobsen, R Chaudhary.   

Abstract

Forty-four clinical samples positive for GB virus C (GBV-C)/hepatitis G virus (HGV) were tested with six primer sets, four from the 5' untranslated region (5'-UTR) and two from the NS5a genomic region. Two of the 5'-UTR primer sets, when used in a single-round 60-cycle PCR, detected between 86.4 and 97.7% of the positive samples, while two different sets from the same area, when used in a nested PCR, amplified between 97.7 and 100% of the positive specimens. Both sets from the NS5a region, when used in a single-round PCR, detected 95.5% of the GBV-C/HGV-positive samples. Parallel testing with two PCR sets, one from the 5'-UTR and a second from NS5a, may eliminate false-negative results attributable to the genetic heterogeneity of the virus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9431969      PMCID: PMC124856     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Detection of GB virus-C/hepatitis G virus RNA in serum by reverse transcription polymerase chain reaction.

Authors:  B Bhardwaj; K Qian; J Detmer; M Mizokami; J A Kolberg; M S Urdea; G Schlauder; J M Linnen; J P Kim; G L Davis; J Y Lau
Journal:  J Med Virol       Date:  1997-05       Impact factor: 2.327

2.  Infection with GB virus C in patients with chronic liver disease.

Authors:  Y Sugai; H Nakayama; M Fukuda; N Sawada; T Tanaka; F Tsuda; H Okamoto; Y Miyakawa; M Mayumi
Journal:  J Med Virol       Date:  1997-03       Impact factor: 2.327

3.  Phylogenetic analysis of GB virus C: comparison of isolates from Africa, North America, and Taiwan.

Authors:  J H Kao; P J Chen; S C Hsiang; W Chen; D S Chen
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

4.  Simplified hot start PCR.

Authors:  D E Birch
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

7.  Infection with hepatitis G virus among recipients of plasma products.

Authors:  L M Jarvis; F Davidson; J P Hanley; P L Yap; C A Ludlam; P Simmonds
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  Evaluation of four PCR systems amplifying different genomic regions for molecular diagnosis of GB virus C infections.

Authors:  J F Cantaloube; R N Charrel; H Attoui; P Biagini; P De Micco; X De Lamballarie
Journal:  J Virol Methods       Date:  1997-03       Impact factor: 2.014

9.  Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome.

Authors:  J H Kao; P J Chen; W Chen; S C Hsiang; M Y Lai; D S Chen
Journal:  J Med Virol       Date:  1997-04       Impact factor: 2.327

10.  Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent.

Authors:  J Linnen; J Wages; Z Y Zhang-Keck; K E Fry; K Z Krawczynski; H Alter; E Koonin; M Gallagher; M Alter; S Hadziyannis; P Karayiannis; K Fung; Y Nakatsuji; J W Shih; L Young; M Piatak; C Hoover; J Fernandez; S Chen; J C Zou; T Morris; K C Hyams; S Ismay; J D Lifson; G Hess; S K Foung; H Thomas; D Bradley; H Margolis; J P Kim
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

View more
  2 in total

1.  Prevalence of GB virus C (also called hepatitis G virus) markers in Norwegian blood donors.

Authors:  S A Nordbø; S Krokstad; P Winge; F E Skjeldestad; A B Dalen
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Hepatitis G virus exposure in dialysis patients.

Authors:  Ali Eslamifar; Rasool Hamkar; Amitis Ramezani; Farrokhlagha Ahmadi; Latif Gachkar; Somayeh Jalilvand; Ladan Adibi; Shahnaz Atabak; Ali Khameneh; Ramin Ghadimi; Arezoo Aghakhani
Journal:  Int Urol Nephrol       Date:  2007-09-05       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.